Vaccines

19 Sep 2011 NovaDigm Therapeutics Presents Positive Phase 1 Safety and Immunogenicity Data for NDV-3 Vaccine
19 Sep 2011 NovaDigm Therapeutics Presents Positive Preclinical Data in Vulvovaginal Candidiasis for NDV-3 Vaccine
19 Sep 2011 Dynavax Reports Complete Results From the HEPLISAV(TM) Phase 3 Trial in Healthy Adults Over Age 40
16 Sep 2011 GlycoVaxyn's Staphylococcus aureus Bioconjugate Vaccine Candidate Protects Mice Against Invasive S. aureus Infection
15 Sep 2011 VBI Announces Acquisition of Epixis and its Innovative eVLP Vaccine Platform
15 Sep 2011 Novel anthrax vaccine and antitoxin being developed with federal support
14 Sep 2011 Merck Statement on GARDASIL
14 Sep 2011 Results From Phase IIB Placebo Controlled Study of Bionor Pharma's Vacc-4x Show Excellent Safety Profile, Statistically Significant Viral Load Reduction in Patients With HIV Who Suspend Antiretroviral Therapy
14 Sep 2011 Inovio Pharmaceuticals Completes PENNVAX-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses
13 Sep 2011 Inovio Pharmaceuticals' PENNVAX-G Global HIV Vaccine Plus MVA Boost Achieves 100% Antigen-Specific T-Cell Immune Responses in Interim Phase I Data
12 Sep 2011 NovaDigm Therapeutics to Present Positive Clinical and Preclinical Data for NDV-3 Vaccine at ICAAC
12 Sep 2011 ImmunoCellular Therapeutics Announces 55% Overall Survival at Three years from Phase I Study in Glioblastoma
12 Sep 2011 RXi Pharmaceuticals Provides Positive NeuVax Phase 3 Clinical Trial Update
08 Sep 2011 Initial Trial of Sanaria's Malaria Vaccine Yields Positive Results
08 Sep 2011 NOVAVAX Announces Publication of Results from H5N1 Influenza Virus-Like Particle Vaccine Phase I/IIa Clinical Trial
07 Sep 2011 ImmunoCellular Therapeutics gives Site Update for Phase II trial of ICT-107
01 Sep 2011 Pevion grants CSL option right to its therapeutic Candida vaccine
31 Aug 2011 Sirona Biochem Develops Cancer Vaccine Antigen
31 Aug 2011 Selecta Biosciences Awarded Subcontract to Develop a Synthetic Nanoparticle Vaccine for Malaria
29 Aug 2011 Positive avian flu trial data using Isconova’s Matrix M published
26 Aug 2011 Results of Emergent BioSolutions Phase 1a Study on Adjuvanted BioThrax Anthrax Vaccine Published in the Journal Vaccine
25 Aug 2011 Bionor Pharma ASA Announces Exploratory Study of Its Lead Therapeutic HIV-Vaccine Candidate Vacc-4x in Combination With Leading Cancer Drug
24 Aug 2011 NanoBio’s Intranasal RSV Vaccine Induces Robust Immunity in Animals
22 Aug 2011 Mayo Clinic Receives FDA Approval for Ovarian and Breast Cancer Vaccines
22 Aug 2011 Isconova and Genocea expand collaboration

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top